Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP & Chief Financial Officer | April 01, 2023 | April 04, 2023 |
| DAVITA INC.DVA · Entity 3482 | Director | May 15, 2021 | May 19, 2021 |
| Evolent Health, Inc.EVH · Entity 5492 | Director | June 04, 2026 | June 08, 2026 |
| TRINET GROUP, INC.TNET · Entity 4202 | Director | March 24, 2021 | March 26, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date April 01, 2023 · Filed April 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.31 · Expires 2033-04-01 | Direct | 148,456 |
Reported balance
After 2023-04-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-04-01 · Grant · Acquired 148,456 · Balance 148,456 F2: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2031-05-28 | Direct | 97,562 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 97,562 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $101.09 · Expires 2032-04-01 | Direct | 103,950 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 103,950 F1: Option became exercisable in four equal installments, commencing 4/1/2023. |
| Common StockSEC Table I · non-derivative | Direct | 9,260 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 9,260 |
| Common Stock (Restricted)SEC Table I · non-derivative | Direct | 34,706 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 34,706 |
Filing footnotes · ownership attribution and instrument terms
F1: Option became exercisable in four equal installments, commencing 4/1/2023.
F2: Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
DAVITA INC.
Report date May 15, 2021 · Filed May 19, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,105 |
Reported balance
After 2021-05-15 transaction · row 1
1 source rowRow 1 · 2021-05-15 · Grant · Acquired 379 · Balance 1,105 |
Evolent Health, Inc.
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 63,075 |
Reported balance
After 2026-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 41,096 · Balance 63,075 F1: Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
TRINET GROUP, INC.
Report date March 24, 2021 · Filed March 26, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,560 |
Reported balance
After 2021-03-24 transaction · row 1
1 source rowRow 1 · 2021-03-24 · Grant · Acquired 2,576 · Balance 8,560 F1: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the date of the Company's 2022 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the date of the Company's 2022 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AETNA INC /PA/
Report date November 28, 2018 · Filed November 28, 2018
Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 1
1 source rowRow 1 · 2018-11-28 · Disposition to issuer · Disposed 11,058 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectBy 2018 GRAT | 0 |
Reported balance
After 2018-11-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-11-28 · Disposition to issuer · Disposed 11,174 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F2: Represents shares held in 2018 Grantor Retained Annuity Trust ("GRAT") for which the Reporting Person is sole trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy 2018 CRUT | 0 |
Reported balance
After 2018-11-28 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-11-28 · Disposition to issuer · Disposed 25,000 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F3: Represents shares held in 2018 Charitable Remainder Unitrust ("CRUT") for which the Reporting Person is sole trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2018-11-28 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2018-11-28 · Disposition to issuer · Disposed 634.7406 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F4: Represents the pro rata portion of the stock portion of the Aetna Common Stock Fund held by Reporting Person on October 31, 2018 pursuant to the Aetna Inc. 401(k) Plan. The information is based on information provided by the Plan Trustee as of that date. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $100.50 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-11-28 · Disposition to issuer · Disposed 25,715 · Balance 0 F5: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $116.44 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-11-28 · Disposition to issuer · Disposed 11,415 · Balance 0 F6: Represents SARs granted under the Plan on September 24, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $103.45 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-11-28 · Disposition to issuer · Disposed 55,376 · Balance 0 F7: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $125.27 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-11-28 · Disposition to issuer · Disposed 81,864 · Balance 0 F8: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-11-28 · Disposition to issuer · Disposed 23,780 · Balance 0 F9: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-11-28 · Disposition to issuer · Disposed 10,179 · Balance 0 F10: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-11-28 · Disposition to issuer · Disposed 23,940 · Balance 0 F11: RSUs under the Plan granted on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
F2: Represents shares held in 2018 Grantor Retained Annuity Trust ("GRAT") for which the Reporting Person is sole trustee.
F3: Represents shares held in 2018 Charitable Remainder Unitrust ("CRUT") for which the Reporting Person is sole trustee.
F4: Represents the pro rata portion of the stock portion of the Aetna Common Stock Fund held by Reporting Person on October 31, 2018 pursuant to the Aetna Inc. 401(k) Plan. The information is based on information provided by the Plan Trustee as of that date.
F5: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount").
F6: Represents SARs granted under the Plan on September 24, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount.
F7: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.
F8: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.
F9: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement.
F10: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement.
F11: RSUs under the Plan granted on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 8, 2026 20:26 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 41,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-26-000051 · wk-form4_1780950371.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,075 F1 · security: Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 11:18 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 21,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000094 · wk-form4_1749467905.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,979 F1 · security: Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 148,456 | $74.31 Strike: $74.31 | $11,031,765.36 |
DisclosureSEC source: 0001127602-23-012226 · form4.xml · derivative · entry 5 GUERTIN SHAWN M · CIK 0001231553 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,456 Underlying: Common Stock · 148,456 shares Expires 2033-04-01 F2 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 103,950 | $101.09 Strike: $101.09 | $10,508,305.50 |
DisclosureSEC source: 0001127602-22-011634 · form4.xml · derivative · entry 3 GUERTIN SHAWN M · CIK 0001231553 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,950 Underlying: Common Stock · 103,950 shares Expires 2032-04-01 F1 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 97,562 | $86.44 Strike: $1.00 | $8,433,259.28 |
DisclosureSEC source: 0001127602-21-018741 · form4.xml · derivative · entry 3 GUERTIN SHAWN M · CIK 0001231553 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,562 Underlying: Common Stock · 97,562 shares Expires 2031-05-28 F2 · shares: Option becomes exercisable in four equal annual installments, commencing 5/28/2022. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 34,706 | $86.44 | $2,999,986.64 |
DisclosureSEC source: 0001127602-21-018741 · form4.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,706 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 5/28/2024. Read SEC document |
| May 15, 2021 Filed May 19, 2021 00:21 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 379 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-21-000098 · wf-form4_162138364461801.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 21:30 UTC | TRINET GROUP, INC. TNET · Entity 4202 | GrantCommon Stock | 2,576 | $0.00 | $0.00 |
DisclosureSEC source: 0000937098-21-000095 · wf-form4_161679422310466.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,560 F1 · shares: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the date of the Company's 2022 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:39 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-21-000050 · wf-form4_161601716305307.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 726 Read SEC document |
| November 15, 2020 Filed Nov 18, 2020 02:13 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-20-000240 · wf-form4_160566560166394.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290 Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 22:12 UTC | TRINET GROUP, INC. TNET · Entity 4202 | GrantCommon Stock | 5,773 | $0.00 | $0.00 |
DisclosureSEC source: 0000937098-20-000124 · wf-form4_158534715377902.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,984 F1 · shares: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on March 25, 2021. The Restricted Stock Units are also subject to accelerated vesting upon certain events. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 00:27 UTC | TRINET GROUP, INC. TNET · Entity 4202 | Exercise / conversionRestricted Stock Units · Derivative | 211 | $0.00 | $0.00 |
DisclosureSEC source: 0000937098-20-000060 · wf-form4_158138080838508.xml · derivative · entry 2 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 211 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to common stock of TNET on a one-to-one basis. F2 · derivative.exercise_date: The restricted stock units vested 100% on February 6, 2020. F2 · derivative.expiration_date: The restricted stock units vested 100% on February 6, 2020. Read SEC document |
| February 06, 2020 Filed Feb 11, 2020 00:27 UTC | TRINET GROUP, INC. TNET · Entity 4202 | Exercise / conversionCommon Stock | 211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000937098-20-000060 · wf-form4_158138080838508.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock of TNET on a one-to-one basis. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 22:52 UTC | TRINET GROUP, INC. TNET · Entity 4202 | GrantRestricted Stock Units · Derivative | 211 | $0.00 | $0.00 |
DisclosureSEC source: 0000937098-20-000031 · wf-form4_157930151962781.xml · derivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211 Underlying: Common Stock · 211 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TNET common stock. F2 · derivative.exercise_date: The restricted stock units ("RSUs") will vest 100% on February 6, 2020. The RSUs are also subject to accelerated vesting upon certain events. F2 · derivative.expiration_date: The restricted stock units ("RSUs") will vest 100% on February 6, 2020. The RSUs are also subject to accelerated vesting upon certain events. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerRestricted Stock Units · Derivative | 23,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · derivative · entry 11 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,940 shares Expires not disclosed F11 · derivative.exercise_price: RSUs under the Plan granted on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. F11 · price: RSUs under the Plan granted on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. F11 · derivative.exercise_date: RSUs under the Plan granted on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. F11 · derivative.expiration_date: RSUs under the Plan granted on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerPerformance Stock Units · Derivative | 10,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · derivative · entry 10 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,179 shares Expires not disclosed F10 · derivative.exercise_price: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. F10 · price: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. F10 · derivative.exercise_date: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. F10 · derivative.expiration_date: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerPerformance Stock Units · Derivative | 23,780 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · derivative · entry 9 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,780 shares Expires not disclosed F9 · derivative.exercise_price: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. F9 · price: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. F9 · derivative.exercise_date: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. F9 · derivative.expiration_date: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 81,864 | Not disclosed Strike: $125.27 | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · derivative · entry 8 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 81,864 shares Expires not disclosed F8 · price: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F8 · derivative.exercise_date: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F8 · derivative.expiration_date: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 55,376 | Not disclosed Strike: $103.45 | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · derivative · entry 7 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,376 shares Expires not disclosed F7 · price: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F7 · derivative.exercise_date: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F7 · derivative.expiration_date: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 11,415 | Not disclosed Strike: $116.44 | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · derivative · entry 6 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,415 shares Expires not disclosed F6 · price: Represents SARs granted under the Plan on September 24, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount. F6 · derivative.exercise_date: Represents SARs granted under the Plan on September 24, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount. F6 · derivative.expiration_date: Represents SARs granted under the Plan on September 24, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to the SAR Amount. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 25,715 | Not disclosed Strike: $100.50 | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · derivative · entry 5 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,715 shares Expires not disclosed F5 · price: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). F5 · derivative.exercise_date: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). F5 · derivative.expiration_date: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerCommon Stock | 634.7406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · nonDerivative · entry 4 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F4 · ownership.nature: Represents the pro rata portion of the stock portion of the Aetna Common Stock Fund held by Reporting Person on October 31, 2018 pursuant to the Aetna Inc. 401(k) Plan. The information is based on information provided by the Plan Trustee as of that date. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · nonDerivative · entry 3 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2018 CRUT Disclosed balance after: 0 F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F3 · ownership.nature: Represents shares held in 2018 Charitable Remainder Unitrust ("CRUT") for which the Reporting Person is sole trustee. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerCommon Stock | 11,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · nonDerivative · entry 2 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2018 GRAT Disclosed balance after: 0 F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F2 · ownership.nature: Represents shares held in 2018 Grantor Retained Annuity Trust ("GRAT") for which the Reporting Person is sole trustee. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerCommon Stock | 11,058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000160 · edgar.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 16:12 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversion2015 Performance Stock Units · Derivative | 1,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000131 · edgar.xml · derivative · entry 7 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,546 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each Performance Stock Unit represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. F9 · derivative.exercise_date: Vesting of previously reported PSUs granted under the Plan on September 24, 2015. F9 · derivative.expiration_date: Vesting of previously reported PSUs granted under the Plan on September 24, 2015. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 16:12 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 861 | $203.40 | $175,127.40 |
DisclosureSEC source: 0001122304-18-000131 · edgar.xml · nonDerivative · entry 3 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,058 F2 · shares: Represents tax withholding on previously reported PSUs granted under the Plan. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 16:12 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 1,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000131 · edgar.xml · nonDerivative · entry 2 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Performance Stock Units (PSUs) granted under the 2010 Stock Incentive Plan (the "Plan"). Read SEC document |
| June 26, 2018 Filed Sep 26, 2018 16:12 UTC | AETNA INC /PA/ AET · Entity 107289 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000131 · edgar.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,237 Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:14 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantRestricted Stock Units · Derivative | 23,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000031 · edgar.xml · derivative · entry 5 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,940 Underlying: Common Stock · 23,940 shares Expires not disclosed F6 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F7 · derivative.exercise_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. F7 · derivative.expiration_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:14 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionPerformance Stock Units · Derivative | 10,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000031 · edgar.xml · derivative · entry 4 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. F5 · derivative.exercise_date: PSUs granted under the Plan. F5 · derivative.expiration_date: PSUs granted under the Plan. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:14 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 5,684 | $177.53 | $1,009,080.52 |
DisclosureSEC source: 0001122304-18-000031 · edgar.xml · nonDerivative · entry 2 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,737 F3 · shares: Represents tax withholding on vesting of previously reported PSUs. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:14 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 12,538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000031 · edgar.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Performance Stock Units ("PSUs") granted under the 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantPerformance Stock Units · Derivative | 1,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000132 · edgar.xml · derivative · entry 4 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,546 Underlying: Common Stock · 1,546 shares Expires not disclosed F2 · derivative.exercise_price: Performance Stock Units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan. Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net taxes, depending on performance against the specified Company performance target. F4 · derivative.exercise_date: PSUs originally granted on September 24, 2015. Units vest based on both service through September 24, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through September 24, 2018. F4 · derivative.expiration_date: PSUs originally granted on September 24, 2015. Units vest based on both service through September 24, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through September 24, 2018. Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantPerformance Stock Units · Derivative | 10,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000132 · edgar.xml · derivative · entry 3 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,448 Underlying: Common Stock · 10,448 shares Expires not disclosed F2 · derivative.exercise_price: Performance Stock Units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan. Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net taxes, depending on performance against the specified Company performance target. F3 · derivative.exercise_date: PSUs originally granted on March 2, 2015. Units vest based on both service through March 2, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through March 2, 2018. F3 · derivative.expiration_date: PSUs originally granted on March 2, 2015. Units vest based on both service through March 2, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through March 2, 2018. Read SEC document |
| December 18, 2017 Filed Dec 21, 2017 16:19 UTC | AETNA INC /PA/ AET · Entity 107289 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000132 · edgar.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,883 Read SEC document |
| March 23, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | SaleCommon Stock | 8,434 | $128.41 | $1,083,009.10 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · nonDerivative · entry 8 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,880 F3 · price: Average weighted share price. Shares sold in multiple transactions at prices ranging from $128.25 to $128.62, inclusive. Read SEC document |
| March 22, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionStock Appreciation Rights · Derivative | 27,688 | $103.45 Strike: $103.45 | $2,864,323.60 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · derivative · entry 12 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,376 Underlying: Common Stock · 27,688 shares Expires 2026-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionStock Appreciation Rights · Derivative | 51,431 | $100.50 Strike: $100.50 | $5,168,815.50 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · derivative · entry 11 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,715 Underlying: Common Stock · 51,431 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 70,685 | $128.33 | $9,071,006.05 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · nonDerivative · entry 7 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,314 F2 · shares: Stock Appreciation Right is net settled; amount represents withholding of shares by the Company to pay exercise price and taxes. Read SEC document |
| March 22, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 27,688 | $103.45 | $2,864,323.60 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · nonDerivative · entry 6 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 51,431 | $100.50 | $5,168,815.50 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · nonDerivative · entry 5 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | SaleCommon Stock | 9,497 | $128.61 | $1,221,378.78 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · nonDerivative · entry 4 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,880 Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionStock Appreciation Rights · Derivative | 42,250 | $72.26 Strike: $72.26 | $3,052,985.00 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · derivative · entry 10 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,250 shares Expires 2024-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 32,753 | $129.09 | $4,228,084.77 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · nonDerivative · entry 3 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,377 F2 · shares: Stock Appreciation Right is net settled; amount represents withholding of shares by the Company to pay exercise price and taxes. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 42,250 | $72.26 | $3,052,985.00 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · nonDerivative · entry 2 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | SaleCommon Stock | 11,671 | $130.62 | $1,524,513.87 |
DisclosureSEC source: 0001122304-17-000036 · edgar.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,880 F1 · price: Average weighted share price. Shares sold in multiple transactions at prices ranging from $130.610 to $130.734, inclusive. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:46 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionPerformance Stock Units · Derivative | 11,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000024 · edgar.xml · derivative · entry 4 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,210 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Performance Stock Unit represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. F4 · derivative.exercise_date: Performance Stock Units granted under the Plan. F4 · derivative.expiration_date: Performance Stock Units granted under the Plan. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:46 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 10,752 | $130.69 | $1,405,178.88 |
DisclosureSEC source: 0001122304-17-000024 · edgar.xml · nonDerivative · entry 2 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,551 F3 · shares: Represents tax withholding on vesting of previously reported Performance Stock Units. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:46 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 22,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-17-000024 · edgar.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Exec. Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Performance Stock Units granted under the 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each Performance Stock Unit represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.